Sanofi
Antigenic Multimeric Respiratory Syncytial Virus Polypeptides
Last updated:
Abstract:
This disclosure relates to antigenic multimeric respiratory syncytial virus (RSV) G polypeptides for use in eliciting an immune response to RSV.
Status:
Application
Type:
Utility
Filling date:
29 Sep 2021
Issue date:
21 Apr 2022